SCHEMBL3485503

SCHEMBL3485503

OCc1cc(Br)ccc1Oc1c[c]c(C(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.47
PTGDR2 Q9Y5Y4 1/20 0.41
SLC6A2 P23975 1/20 0.37
SLC6A3 Q01959 1/20 0.37
EPAS1 Q99814 3/20 0.37
HTR2A P28223 2/20 0.36
KCNH2 Q12809 2/20 0.36
HRH3 Q9Y5N1 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 2/20 0.35
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
VEGFA P15692 1/20 0.33
USP28 Q96RU2 2/20 0.32
USP25 Q9UHP3 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3485384 0.77 SLC6A4 (0.44) SLC6A4EPAS1HTR2AKCNH2RAB9A
SCHEMBL29029436 0.73 PTGDR2 (0.61) SLC6A4PTGDR2SLC6A2SLC6A3HTR2A
SCHEMBL3484951 0.73 PTGDR2 (0.44) SLC6A4PTGDR2SLC6A2SLC6A3HTR2A
SCHEMBL3485421 0.72 PTGDR2 (0.43) SLC6A4PTGDR2SLC6A2SLC6A3EPAS1
SCHEMBL25370095 0.70 PTGDR2 (0.58) SLC6A4PTGDR2MAPK1HSD17B10NPC1
SCHEMBL3372357 0.70 PTGDR2 (0.53) SLC6A4PTGDR2SLC6A2MAPK1HSD17B10
SCHEMBL14097989 0.69 PTGDR2 (0.49) SLC6A4PTGDR2SLC6A2SLC6A3HTR2A
SCHEMBL1645241 0.67 SLC6A4 (0.42) SLC6A4PTGDR2SLC6A2SLC6A3HTR2A
SCHEMBL972400 0.66 CYP2A6 (0.32)
SCHEMBL5903450 0.65 LTA4H (0.44) RAB9AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257536-A2 CYCLIC DIARYL ETHER AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS Amira Pharmaceuticals, Inc. (US) 2010-12-08 EP disclosed
WO-2009102893-A2 CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors AMIRA PHARMACEUTICALS, INC. (US) 2009-08-20 WO disclosed